Use of pre-, pro- and synbiotics in patients with acute pancreatitis: A meta-analysis

Table 2 Surgical outcomes from randomized studies included in this meta-analysis

Trial	No. of patients	Septic morbidity (%)	MOF (%)	SIRS (%)	Pancreatic infections (%)	Surgical interventions (%)	Hospital stay (d)	Mortality (%)
Oláh et al[16]	22/23	5 (22.7)/ 20 (87)	2 (9.1)/ 2 (8.7)	11 (50)/ 6 (26.1)	1 (4.5)/ 7 (30.4)	1 (4.5)/ 7 (30.4)	13.7/21.4 (median)	1 (4.5)/2 (8.7)
Oláh et al[17]	33/29	9 (27.3)/ 15 (51.7)	5 (15.1)/ 9 (31)	3 (9)/ 5 (17.2)	4 (12.1)/ 8 (27.6)	4 (12.1)/ 7 (24.1)	14.9/19.7 (median)	2 (6.1)/6 (20.7)
Karakan et al[25]	15/15	2 (13.3)/ 2 (13.3)	1 (6.7)/ 2 (13.3)	N/A	N/A	N/A	10 ± 4/15 ± 6	2 (13.3)/4 (26.7)
Qin et al[18]	36/38	11 (30.6)/ 29 (76.3)	4 (11.1)/ 7 (18.4)	6 (16.7)/ 14 (36.8)	N/A	N/A	20.9/24.2 (median)	0 (0)/0 (0)
Besselink et al[19]	152/144	46 (30.3)/ 41 (28.47)	33 (22)/ 15 (10)	N/A	21 (14)/ 14 (10)	28 (18)/ 14 (10)	28.9 ± 41.5/23.5 ± 25.9	24 (16)/9 (6)
Li et al[26]	14/11	N/A	N/A	N/A	N/A	N/A	42 ± 5/49 ± 6.8	N/A
Wu et al[27]	14/13	N/A	N/A	N/A	N/A	N/A	34 ± 6/40 ± 6	5 (35.7)/6 (46.2)

N/A: Not applicable; MOF: Multi-organ failure; SIRS: Systemic inflammatory response syndrome.